Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers

Journal of Clinical Psychiatry

Volumn 58, Issue 8, 1997, Pages 348-350

  Salín Pascual, Rafael J ^a,b,d   Galicia Polo, Lourdes ^b   Drucker Colín, René ^b,c  

^a SECRETARÍA DE SALUD   (Mexico)

^b Facultad de Medicina ^*  (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NORADRENALIN; SEROTONIN; VENLAFAXINE;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN EXPERIMENT; LEG MOVEMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SLEEP STAGE; WAKEFULNESS;

EID: 1842411343     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n0803     Document Type: Article

References (13)

1. Muth EA, Haskins JT, Moyer JA, et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986;35:4493-4497
2. Entsuah R, Upton GV, Rudolph R. Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: a meta-analysis. Human Psychopharmacology 1995;10:195-200
3. Feighner JP. The role of venlafaxine in rational antidepressant therapy. J Clin Psychiatry 1994;55(9, suppl A):62-70
4. Clerc GE, Ruimy P, Verdeau-Pailles J. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 1994;9:139-143
5. Fritsch Montero R, Riedmann D, Berger D. Antidepressant and antimanic drugs. In: Kales A, ed. The Pharmacology of Sleep. Berlin, Germany: Springer-Verlag; 1995:465-490
6. Salín-Pascual RJ, López-Moro ML. Effects of venlafaxine in the sleep architecture of rats. Psychopharmacology (Berl) 1997;129:295-296
7. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R. New York, NY: Biometric Research, New York State Psychiatric Institute; 1990
8. Rectschaffen A, Kales AA. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, DC: Public Health Service; 1968
9. Wauquier A. Pharmacology of the catecholaminergic system. In: Kales A, ed. The Pharmacology of Sleep. Berlin, Germany: Springer-Verlag; 1995:65-90
10. Adrien J. The serotoninergic system and sleep-wakefulness regulation. In: Kales A, ed. The Pharmacology of Sleep. Berlin, Germany: Springer-Verlag; 1995:91-115
11. Dessauer M, Goetze U, Tolle R. Periodic sleep deprivation in drug-refractory depression. Neuropsychobiology 1985;13:111-116
12. Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 1993;16:713-716
13. Terao T, Terao M, Yoshimura R, et al. Restless legs induced by lithium. Biol Psychiatry 1991;30:167-170